CLINICAL_TRIALS
trial_result
· 2019-01-30
Clinical Trial Update: A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia [Phase 2]
Summary
A Phase 2 double-blind trial evaluating adjunctive valacyclovir to improve cognition in early-phase schizophrenia has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indiana University | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2019-01-30